FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $318,493 | -18.1% | 810,416 | 0.0% | 0.07% | -20.0% |
| Q4 2022 | $389,000 | -71.2% | 810,416 | 0.0% | 0.08% | -69.9% |
| Q3 2022 | $1,353,000 | -41.2% | 810,416 | 0.0% | 0.28% | -40.6% |
| Q2 2022 | $2,302,000 | -43.5% | 810,416 | 0.0% | 0.48% | -34.3% |
| Q1 2022 | $4,076,000 | -49.6% | 810,416 | 0.0% | 0.72% | -42.7% |
| Q4 2021 | $8,080,000 | -23.3% | 810,416 | 0.0% | 1.26% | -26.3% |
| Q3 2021 | $10,535,000 | -7.6% | 810,416 | 0.0% | 1.71% | -0.5% |
| Q2 2021 | $11,403,000 | -12.9% | 810,416 | 0.0% | 1.72% | +54.0% |
| Q1 2021 | $13,088,000 | – | 810,416 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |